Redmile as of June 30, 2014
Portfolio Holdings for Redmile
Redmile holds 47 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actavis | 4.8 | $39M | 177k | 223.05 | |
| Medtronic | 4.6 | $38M | 590k | 63.76 | |
| Array BioPharma | 4.5 | $37M | 8.1M | 4.56 | |
| Universal Health Services (UHS) | 4.3 | $35M | 370k | 95.76 | |
| Hca Holdings (HCA) | 4.2 | $35M | 615k | 56.38 | |
| Receptos | 3.9 | $32M | 754k | 42.60 | |
| Clovis Oncology | 3.6 | $30M | 724k | 41.41 | |
| Chimerix (CMRX) | 3.6 | $29M | 1.3M | 21.94 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $29M | 468k | 62.21 | |
| Allergan | 3.5 | $29M | 170k | 169.22 | |
| Valeant Pharmaceuticals Int | 3.5 | $29M | 228k | 126.12 | |
| Zimmer Holdings (ZBH) | 3.2 | $27M | 256k | 103.86 | |
| Amicus Therapeutics (FOLD) | 3.1 | $26M | 7.7M | 3.34 | |
| Trivascular Technologies | 2.7 | $22M | 1.5M | 14.37 | |
| Healthways | 2.6 | $22M | 1.2M | 17.54 | |
| Kythera Biopharmaceuticals I | 2.6 | $22M | 560k | 38.37 | |
| Agilent Technologies Inc C ommon (A) | 2.4 | $20M | 347k | 57.44 | |
| Globus Med Inc cl a (GMED) | 2.4 | $20M | 833k | 23.92 | |
| HeartWare International | 2.4 | $20M | 223k | 88.50 | |
| Amgen (AMGN) | 2.3 | $19M | 163k | 118.37 | |
| Stryker Corporation (SYK) | 2.2 | $18M | 214k | 84.32 | |
| NuVasive | 2.2 | $18M | 502k | 35.57 | |
| Rite Aid Corporation | 2.1 | $18M | 2.5M | 7.17 | |
| Nanostring Technologies (NSTGQ) | 2.1 | $17M | 1.1M | 14.95 | |
| Castlight Health | 2.0 | $17M | 1.2M | 14.14 | |
| Intra Cellular Therapies (ITCI) | 2.0 | $17M | 979k | 16.86 | |
| Accuray Incorporated (ARAY) | 2.0 | $16M | 1.9M | 8.80 | |
| Oxford Immunotec Global | 2.0 | $16M | 961k | 16.83 | |
| Cardiovascular Systems | 1.9 | $15M | 493k | 31.16 | |
| Model N (MODN) | 1.8 | $15M | 1.4M | 11.05 | |
| HMS Holdings | 1.4 | $12M | 566k | 20.41 | |
| D Fluidigm Corp Del (LAB) | 1.4 | $12M | 393k | 29.40 | |
| Orthofix International Nv Com Stk | 1.2 | $10M | 281k | 36.25 | |
| Inogen (INGN) | 1.2 | $10M | 451k | 22.56 | |
| Align Technology (ALGN) | 1.2 | $9.8M | 176k | 56.04 | |
| Achaogen | 1.1 | $9.1M | 649k | 13.96 | |
| Prothena (PRTA) | 1.0 | $8.4M | 371k | 22.55 | |
| Derma Sciences | 0.8 | $6.9M | 601k | 11.56 | |
| Flexion Therapeutics | 0.8 | $6.8M | 504k | 13.48 | |
| Geron Corporation (GERN) | 0.8 | $6.6M | 2.1M | 3.21 | |
| Ignyta | 0.6 | $5.3M | 578k | 9.09 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.3 | $2.4M | 9.2k | 256.67 | |
| Market Vectors Etf Tr pharmaceutical | 0.1 | $403k | 6.5k | 62.00 | |
| Intercept Pharmaceuticals In | 0.0 | $251k | 1.1k | 236.35 | |
| Boston Scientific Corporation (BSX) | 0.0 | $128k | 10k | 12.80 | |
| Sunesis Pharmaceuticals | 0.0 | $65k | 10k | 6.50 | |
| Oxygenbiotherapeutics Inccom Par | 0.0 | $51k | 13k | 4.08 |
